There’s No Getting Around Agios Pharmaceuticals Inc (NASDAQ: AGIO) Success

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

Stocks Info

AGIO belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Agios Pharmaceuticals Inc is $1.71B. A total of 0.61 million shares were traded on the day, compared to an average of 641.84K shares.

In the most recent transaction, FOUSE JACQUALYN A sold 7,497 shares of AGIO for 25.90 per share on Apr 10 ’25. After the transaction, the Director now owns 149,220 company shares. In a previous transaction on Apr 08 ’25, FOUSE JACQUALYN A bought 7,497 shares at 25.90 per share.

Among the insiders who sold shares, Burns James William disposed of 4,005 shares on Mar 03 ’25 at a per-share price of $35.54. This resulted in the Chief Legal Officer holding 18,650 shares of AGIO after the transaction. In another insider transaction, Jones Cecilia sold 2,275 shares at $35.54 per share on Mar 03 ’25. Company shares held by the Chief Financial Officer now total 21,843.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, AGIO has a high of $62.58 and a low of $23.42.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. AGIO’s latest balance sheet shows that the firm has $1.02B in Cash & Short Term Investments as of fiscal 2021. There were $97.09M in debt and $59.83M in liabilities at the time. Its Book Value Per Share was $25.33, while its Total Shareholder’s Equity was $1.29B.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AGIO is Buy with a score of 4.22.

Related Posts

Park Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.